PainReform Ltd.
PRFX
1
d
|
$0.8737
-1.83%
-1.87%
29K
|
Health Technology
(0.0% 1d) (-55.3% 1m) (-85.6% 1y) (1.0% 2d) (-3.3% 3d) (-18.1% 7d) (Infinity% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 1,770,329
http://www.painreform.com
Sec Filling | Patents | n/a employees
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
education opioid israel msa
add to watch list Paper trade email alert is off
Press-releases
PainReform Announces Closing of $4 Million Public Offering
Published: 2024-04-18 (Crawled : 18:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: -0.11%
H: 2.3%
C: 1.15%
million offering
PainReform Announces Pricing of $4 Million Public Offering
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: -23.72%
H: 3.66%
C: -1.22%
million offering
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 15.88%
H: 29.44%
C: -23.35%
treatment for
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
Published: 2024-04-02 (Crawled : 12:30) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 9.2%
H: 0.0%
C: -8.95%
prf-110 trial
PainReform Provides Year-End Business Update
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 4.74%
H: 22.11%
C: 15.92%
business update
PainReform to Present at the Microcap Conference in Atlantic City
Published: 2024-01-22 (Crawled : 13:30) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 0.39%
H: 0.26%
C: -7.73%
conference atlantic city microcap
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
Published: 2024-01-03 (Crawled : 13:30) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 7.36%
H: 0.36%
C: -6.84%
prf-110 market
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
Published: 2023-12-26 (Crawled : 23:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 1.54%
H: 8.11%
C: 2.53%
million
PainReform Provides Business Update for the Third Quarter of 2023
Published: 2023-11-15 (Crawled : 21:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 2.82%
H: 3.2%
C: -7.31%
business update
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File
Published: 2023-09-11 (Crawled : 12:30) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 2.8%
H: 1.82%
C: 0.23%
prf-110 fda drug review positive trial
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10